ArticlePDF Available

Invited commentary: The politics of human embryo research and the motivation to achieve PGD

Authors:

Abstract

The idea that biomedical research can be influenced by political events implies a teleological basis indicating that scientific achievements occur because there is a political need. Such a concept appears to have been the reason PGD was fast-tracked to emerge as a biomedical achievement well before its due date, occurring at a time when human embryology was still struggling to reach a reasonable level of efficiency and become adopted as a clinically relevant advance around the world. One story underlying the historical achievement of the HFE Act 1990, enabling regulated embryo research, steps outside the firm ground of biomedical science and encourages the idea that Reproductive BioMedicine Online should embrace a further section enabling articles dealing with 'History, politics and personalities' where these influence biomedical research.
COMMENTARY
Invited commentary: the politics of human
embryo research and the motivation to achieve PGD
John L Yovich
PIVET Medical Centre, 166–168 Cambridge Street, Leederville, Perth, 6007 WA, Australia; Cairns Fertility
Centre, 4th Floor Cairns Central Plaza, 58–60 McLeod Street (Cnr Aplin), Cairns, 4870 Qld, Australia
E-mail address: jlyovich@pivet.com.au
Abstract The idea that biomedical research can be influenced by political events implies a teleological basis indicating that scien-
tific achievements occur because there is a political need. Such a concept appears to have been the reason PGD was fast-tracked to
emerge as a biomedical achievement well before its due date, occurring at a time when human embryology was still struggling to
reach a reasonable level of efficiency and become adopted as a clinically relevant advance around the world. One story underlying
the historical achievement of the HFE Act 1990, enabling regulated embryo research, steps outside the firm ground of biomedical
science and encourages the idea that Reproductive BioMedicine Online should embrace a further section enabling articles dealing
with ‘History, politics and personalities’ where these influence biomedical research. RBMOnline
ª2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
KEYWORDS: HFE Act 1990, history, legislation, personalities, PGD, politics
The article entitled ‘The politics of human embryo
research and the motivation to achieve PGD’ (Theodosiou
and Johnson, 2011), in this issue of Reproductive BioMedi-
cine Online deserves commentary as it steps outside the
‘firm’ scientific ground of biomedical research into the
‘softer’ fields of history and politics. To be fair, Reproduc-
tive BioMedicine Online with its ‘devotion to biomedical
research on human conception and the welfare of the
human embryo’ does seek articles under the topic of
‘Ethics, social, legal, counselling’.
The article centres on four aspects of indisputable fact,
namely: (i) the Warnock Report on IVF tabled in the House
of Lords in Westminster in 1984; (ii) the reactionary Unborn
Children (Protection) Bill introduced by Enoch Powell as a
private member in 1985; (iii) the published reports of 1989
and 1990 concerning preimplantation genetic diagnosis
(PGD) on human embryos by Handyside and his colleagues
at Hammersmith hospital under the leadership of Robert
Winston (Handyside et al., 1989, 1990); and (iv) the
establishment of the HFE Act in 1990 which allowed PGD
as well as regulated research on human embryos.
Theodosiou and Johnson, using impressive scien-
tific-like sleuthing, but inevitably relying on much conver-
sational evidence, jottings, parliamentary records,
minutes from meetings, private papers and documented
conversations with the perceived key stakeholders, create
a suspenseful story to explain the emergent PGD applica-
tion in humans which, in their view, was fast-tracked
some years before its expected due date. Being active
in the IVF field in London with Professor Ian Craft from
1976,I would concur that in the mid-1980s we were still
struggling to make the basic fertilization and embryo cul-
ture technology efficient and, although we had mooted a
potential for wider application (Craft and Yovich, 1979)
including embryo diagnosis with a view to reducing signif-
icant anomalies, at that stage the latter was a deferred
consideration. Many IVF clinics started their foundations
in the mid-1980s with assistance from the earlier pioneers
1472-6483/$ - see front matter ª2011, Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.
doi:10.1016/j.rbmo.2011.02.010
Reproductive BioMedicine Online (2011) 22, 408409
www.sciencedirect.com
www.rbmonline.com
and my experience concurs with the authors that PGD was
not an important consideration at that time.
The appeal of science is that it is a progressively evolving
process, at least from the time of Isaac Newton utilizing the
principles of Scientific Methodology and escaping from the
shackles of religious dogma. The resulting truisms hold until
further hard evidence moves the knowledge a step further.
History and politics, however, are notoriously unreliable
history being a record of events prone to interpretation,
especially by the victors or winners or, nowadays, by the
politically correct and politics being a process by which
groups of people make collective decisions. These processes
tend to cycle and repeat so one does not get the sense of
progressing forward. Nonetheless, Reproductive BioMedi-
cine Online should accept some articles as the perceived
collective wisdom of the day under a title ‘History, politics
and personalities’ as an entertaining but also relevant side
to biomedical research.
With respect to personalities, the article of Theodosiou
and Johnson introduces several who might be seen to be
worthy. The main personality is that of parliamentarian
Enoch Powell (see, for example, www.wikipedia.org/wiki/
Enoch_Powell) and the peculiar role he played in the favour-
able achievements gained in the HFE Act 1990. The Right Hon-
ourable Brigadier Professor John Enoch Powell (1912–1988)
was a remarkable man who was a powerful orator, courted
controversy and had no hesitation in speaking his mind. He
was also capable of changing his allegiances (e.g. from Con-
servative party stalwart to Ulster Unionist Party as well as
supporting Labour to victory in 1974). He was British born
but had an Australian connection, acquiring the Professorship
in Greek at Sydney University at age 25, thereafter enrolling
in the British Army (as an Australian citizen) to join the war in
Europe where he rose from private in 1939 to Brigadier in 1945
as one of only two individuals to progress so rapidly and gain-
ing numerous medals along the way including the Military
Order of the British Empire. Drawing on his deep knowledge
of the classics, he delivered many famous speeches including
his ‘Hola Camp’ speech of 1959, criticizing colleagues who
had a derogatory view of the Mau Mau in Kenya; his 1961
‘Water Tower’ speech whilst he was Health Minister; and
his ‘Rivers of Blood’ speech of 1968 warning of dangers of
unchecked mass immigration from countries of the disinte-
grating Commonwealth. His history makes very interesting
reading from whichever interpretation, including his contro-
versial dealing with victims of the thalidomide sequelae as
Health Minister 1960–1962, as well as his introduction of
the Unborn Children (Protection) Bill 1985.
During the debates leading up to the HFE Act 1990, I
personally believe the medico-scientific input failed to
understand that the public (and politicians on their behalf)
were frightened of our use of the term ‘research’ which
they equated with ‘experimentation’ (viz. the Nuremberg
trials of 1945–1946). This emerged in debates within the
House of Lords, some of which I personally attended during
the 1980s when another relevant personality from the arti-
cle, colleague Professor Robert Winston (see, for example,
www.wikipedia.org/wiki/Robert_Winston) encouraged sev-
eral of us to join him in the public gallery on evenings post
prandial after medical meetings to listen to the erudite
speeches as an alternative to nightclub entertainment. It
was indeed often an enthralling and sometimes intimidating
experience to hear those highly articulate speeches decry-
ing ‘research’ and delivered with powerful British aplomb.
Colleague Robert Winston himself rose to membership as a
Lord in that esteemed chamber as Baron Winston of Ham-
mersmith in 1995, one of his many and varied achievements.
One suspects a background interactive role in the events
underpinning the article of Theodosiou and Johnston and
perhaps we do owe a debt to our colleague for reading
the events so well and saving the day.
From my current perspective, having worked with IVF for
34 years now, the 1980s debates on PGD were actually being
conducted before we had efficient control over the basic
laboratory procedures (Yovich et al., 1984), and outside
London some were reporting IVF as a failed technology
(Wagner and St Clair, 1989). I believe a further important
personality mentioned in the article, Anne McLaren (see,
for example, www.wikipedia.org/wiki/Anne_McLaren), was
well aware of our basic embryology struggles, hence her
initial reticence about embryo biopsy. Even today, aneu-
ploidy screening, or preimplantation genetic screening, is
a challenging subject for numerous reasons and does not
yet fulfil Enoch Powell’s support to prevent children with
disabilities except on a very small scale, although there
remains an expectation of benefits in the future utilizing
the new comprehensive chromosome screening methods at
the blastocyst stage (Wells, 2010).
At least the interesting events described by Theodosiou
and Johnson resulted in a model for the HFE Act 1990
which enabled embryo research and their article makes
a good read with a perspective on that outcome. The
story is certainly plausible but implies a teleological
theme in the sense that the unfolding historical and polit-
ical events had to occur to stimulate the desired biomed-
ical achievement which, in turn, changed the political
debate and historical outcome, again not a conventional
scientific sequence.
References
Craft, I., Yovich, J., 1979. Implications of embryo transfer. Lancet
2, 642–643.
Handyside, A.H., Kontogianni, E.H., Hardy, K., Winston, R.M., 1990.
Pregnancies from biopsied human preimplantation embryos
sexed by Y-specific DNA amplification. Nature 344, 768–770.
Handyside, A.H., Pattinson, J.K., Penketh, R.J., Delhanty, J.D.,
Winston, R.M., Tuddenham, E.G., 1989. Biopsy of human
preimplantation embryos and sexing by DNA amplification.
Lancet 1, 347–349.
Theodosiou, A.A., Johnson, M.H., 2011. The politics of human
embryo research and the motivation to achieve PGD. Reprod.
BioMed. Online 22, 457–471.
Wagner, M.G., St Clair, P.A., 1989. Are in-vitro fertilisation and
embryo transfer of benefit to all. Lancet 2, 1027–1029.
Wells, D., 2010. Embryo aneuploidy and the role of morphological
and genetic screening. Reprod. Biomed. Online 21, 274–277.
Yovich, J.L., Stanger, J.D., Tuvik, A.I., Yovich, J.M., 1984. In-vitro
fertilization in Western Australia a viable service program.
Med. J. Aust. 140, 645–649.
Declaration: The author reports no financial or commercial
conflicts of interest.
Received 25 January 2011; accepted 14 February 2011.
Invited commentary 409
... The potential of biomedicine is a manifestation of political authority in an environment that favors changes in the socioeconomic system, as the latter is shaped and guided by the achievements and the growing expectations in bioscientific research. The science of human Embryonic Stem Cells -aided by evolutionary biology -promises the correction and optimization of human genes, which will result in the production of "advanced", healthy human bioorganisms (Yovich, 2011, Solter et al., 2010. Regenerative Medicine, with its tissue engineering, is approaching new ways of intervention to damaged tissue for the cure of severe conditions, such as Parkinson's disease and Alzheimer (Soria, 2001, Genetic Engineering andBiotechnology News, 2011). ...
Article
Full-text available
The EU policy against poverty and social exclusion, more widely known as “Social Inclusion Strategy”, was launched in the context of the Lisbon Strategy, in 2000. Since Lisbon came to an end, in 2010, there is currently much policy debate about what role efforts to prevent and reduce poverty and social exclusion will play in the EU’s agenda for the next decade, “Europe 2020”. Against this background, the aim of this paper is two-fold. First, to critically examine the EU’s approach to date in combating poverty and social exclusion through the operation of the Open Method of Coordination in social protection and social inclusion. Second, on the basis of this critical assessment, to discuss the limits and potential of the new EU project “Europe 2020” for building a stronger Social Inclusion Strategy.
Article
Full-text available
This article reports a historical study of factors influencing the achievement of clinical preimplantation genetic diagnosis (PGD) in 1990, 22 years after its first demonstration in animals. During the 1970s, research on PGD continued in large farm animals, but serious interest in human PGD was not evident until 1986. First, interest in PGD during the 1970s waned with the advent of prenatal testing, which for gynaecologists was clinically more familiar, technically simpler and ethically less challenging than IVF. Indeed, IVF was viewed with widespread suspicion until the first IVF births in 1978. Second, interest in clinical PGD was stimulated by the UK Parliamentary reaction against human embryo research that greeted the Warnock Report in 1984. This hostility led scientists to initiate a pro-research campaign, further galvanized in 1985 by MP Enoch Powell’s bid to ban such research. However, while Powell abhorred embryo research, he approved of PGD, a stance that divided the anti-research lobby. Accordingly, the campaigners for research emphasized that it was needed to achieve PGD. Powell demanded evidence of such projects and PGD research increased from 1986. It is concluded that UK political debates on embryo research played a critical role in stimulating the achievement of clinical PGD.
Article
Full-text available
A single cell was removed, through a hole made in the zona pellucida, from each of 30 human embryos at the 6-10 cell cleavage stage three days after in-vitro fertilisation. A normal proportion of the embryos (37%) developed to the blastocyst stage by day six in culture and 6 hatched from the zona. Each male embryo was sexed from the DNA by amplification of a repeated sequence specific for the Y chromosome. In 15 embryos with the normal two pronuclei the sex was determined also by in-situ hybridisation with a Y specific probe or fluorescent chromosome staining to detect metaphase Y chromosomes; the results of Y specific amplification were confirmed. This approach may be valuable for couples at risk of transmitting X-linked disease.
Article
Full-text available
A service programme of in-vitro fertilization ( IVF ) and embryo transfer (ET) has been established in a small unit in Western Australia after a successful pilot study which was undertaken in 1981. The key features of the programme include simplified monitoring of the follicular phase of stimulated cycles; oocyte retrieval and ET are both undertaken during routine daytime work schedules. The results of the first eight months of the programme are presented, during which 13 further pregnancies were generated and 10 healthy infants were delivered (seven boys and three girls). In the last session in which 49 patients took part a mean of 2.3 mature preovulatory oocytes were collected by means of a double-lumen aspiration/flushing needle from 98% of 48 patients who reached the laparoscopy stage. Ninety-four per cent of 48 patients proceeded to embryo transfer by means of a double-catheter technique; the pregnancy rate was 20.8% per laparoscopy or 22.7% per embryo transfer.
Article
Chromosome abnormalities are common among human oocytes and are usually lethal to any embryos they produce. It therefore seems logical that a reliable technique for distinguishing between normal and aneuploid embryos would be a useful tool for physicians and embryologists, assisting the choice of which embryo(s) to prioritize for uterine transfer. This concept has led to the development of a variety of methods for the detection of chromosome abnormalities in oocytes and embryos, most often referred to as preimplantation genetic screening (PGS). However, several well-controlled studies have been unable to show an advantage of chromosome screening in terms of pregnancy and birth rates. Some investigators have suggested that damage to embryos, sustained during cleavage-stage biopsy, might explain why PGS has not always provided the anticipated benefits. This paper asks whether there is evidence that a non-invasive, morphological analysis could allow chromosomally normal embryos to be accurately identified and reviews data from the most recent publication concerning IVF outcome following PGS.
Article
Over 200 recessive X chromosome-linked diseases, typically affecting only hemizygous males, have been identified. In many of these, prenatal diagnosis is possible by chorion villus sampling (CVS) or amniocentesis, followed by cytogenetic, biochemical or molecular analysis of the cells recovered from the conceptus. In others, the only alternative is to determine the sex of the fetus. If the fetus is affected by the defect or is male, abortion can be offered. Diagnosis of genetic defects in preimplantation embryos would allow those unaffected to be identified and transferred to the uterus. Here we report the first established pregnancies using this procedure, in two couples known to be at risk of transmitting adrenoleukodystrophy and X-linked mental retardation. Two female embryos were transferred after in vitro fertilization (IVF), biopsy of a single cell at the six- to eight-cell stage, and sexing by DNA amplification of a Y chromosome-specific repeat sequence. Both women are confirmed as carrying normal female twins.
Article
The efficacy, safety, costs, and benefits of in-vitro fertilisation and embryo transfer (IVF/ET) have been reviewed. IVF/ET benefits only a small proportion of infertile women, it is expensive, and has serious health risks. Therefore policies for the management of infertility in which most financial and manpower resources are applied to prevention of infertility must be developed. Health authorities should also require accreditation of IVF/ET programmes, certification of providers, and ongoing monitoring of clinics. Full and accurate information on IVF/ET must also be disseminated, so that individuals seeking treatment for infertility can make the best informed choice about their care and health authorities can decide the place of IVF/ET in their infertility services.
The politics of human embryo research and the motivation to achieve PGD Are in-vitro fertilisation and embryo transfer of benefit to all Embryo aneuploidy and the role of morphological and genetic screening
  • A A Theodosiou
  • M H Johnson
  • M G Wagner
  • St
  • P A Clair
Lancet 1, 347–349. Theodosiou, A.A., Johnson, M.H., 2011. The politics of human embryo research and the motivation to achieve PGD. Reprod. BioMed. Online 22, 457–471. Wagner, M.G., St Clair, P.A., 1989. Are in-vitro fertilisation and embryo transfer of benefit to all. Lancet 2, 1027–1029. Wells, D., 2010. Embryo aneuploidy and the role of morphological and genetic screening. Reprod. Biomed. Online 21, 274–277. Yovich, J.L., Stanger, J.D., Tuvik, A.I., Yovich, J.M., 1984. In-vitro fertilization in Western Australia – a viable service program